Hudson Global Reports 2020 Second Quarter Results
OLD GREENWICH, Conn., Aug. 05, 2020 (GLOBE NEWSWIRE) — Hudson Global, Inc. (Nasdaq: HSON), a leading global total talent solutions […]
American Society of Radiologic Technologists Approves Sensus Healthcare’s SRT Systems for Continuing Education Units
Beginning September 1, Category A credits will be available for in-person trainings on the SRT-100™, SRT-100+™ and SRT-100 Vision™ systemsBOCA […]
Pacific Ethanol to Release Second Quarter 2020 Results
SACRAMENTO, Calif., Aug. 05, 2020 (GLOBE NEWSWIRE) — Pacific Ethanol, Inc. (NASDAQ: PEIX), a leading producer and marketer of low-carbon […]
IEC Announces Fiscal 2020 Third Quarter Results
REVENUE OF $47.4 MILLION; UP 17% YEAR OVER YEARGROSS MARGIN OF 14%GENERATED $6.0 MILLION OF OPERATING CASH FLOWNEWARK, N.Y., Aug. […]
Bellerophon Provides Clinical Program Update and Reports Second Quarter 2020 Financial Results
WARREN, N.J., Aug. 05, 2020 (GLOBE NEWSWIRE) — Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics […]
Option Care Health to Participate in the Canaccord Genuity Virtual Growth Conference
BANNOCKBURN, Ill., Aug. 05, 2020 (GLOBE NEWSWIRE) — Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest […]
NextCure to Present at BTIG Virtual Biotechnology Conference
BELTSVILLE, Md., Aug. 05, 2020 (GLOBE NEWSWIRE) — NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and […]
Zscaler Internet Access Achieves FedRAMP “In Process” Status at High Impact Level
SAN JOSE, Calif., Aug. 05, 2020 (GLOBE NEWSWIRE) — Zscaler, Inc. (NASDAQ: ZS), the leader in cloud security, today announced […]
Applied Molecular Transport Named as One of Three Finalists for the Fierce Innovations Awards for AMT-101
SOUTH SAN FRANCISCO, Calif., Aug. 05, 2020 (GLOBE NEWSWIRE) — Applied Molecular Transport (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, […]
Allena Pharmaceuticals Announces Second Quarter 2020 Financial Results and Provides Business Update
— Expanding URIROX-2 Trial Sites; Interim Analysis on Track for the First Quarter of 2022 –-— Initiated Phase 1 Clinical […]
